EVGN Evogene Ltd.

0.4106USD-3.09%Mkt Cap: 6.49M $P/E: —

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Ap…

HeadlineSourceTime
Older
Evogene (EVGN) Q2 2026 Earnings Call Transcript

AI-driven computational chemistry platform advances pharma partnerships while cutting cash burn.

Motley Fool
Evogene Ltd. Q2 2026 Earnings Call Summary

Moby summary of Evogene Ltd.'s Q2 2026 earnings call

Moby
Evogene Ltd (EVGN) (Q2 2026) Earnings Call Highlights: Strategic Pivot to AI-Driven Drug ...

Evogene Ltd (EVGN) advances ChemPass AI platform with six new collaborations while navigating shareholder challenges and a leaner cost structure.

GuruFocus.com
Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report

Download the Complete Report Here Cibus, Inc. (CBUS) Interoc Expands Rice Pipeline to Five Traits; Platform Revenue and Cost Discipline Advance as LATAM Launch Moves to 2028 Key Takeaways: Rice commercialization advanced as Interoc testing began and the relationship expanded from two to five traits, although initial LATAM launch timing moved to 2028. Sustainable Ingredients […] The post Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report appeared first

Exec Edge
Evogene and ELEO to develop new oral PCSK9 inhibitors

ELEO will provide experimental resources and screening platforms to test and refine molecules produced via computational methods.

Pharmaceutical Technology
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection

Download the Complete Report Here Cibus, Inc. (CBUS) Rice Royalty Conversion, Precision-Breeding Platform, and BioFragrance Scale-Up Support Commercial Inflection CBUS is an asset-light precision-breeding platform that develops productivity traits for seed-company partners, rather than owning seed production, distribution or farmer relationships. RTDS and the Trait Machine process are designed to edit elite customer germplasm and […] The post Cibus Inc’s Precision-Breeding Platform and BioFragra

Exec Edge
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report

Cibus, Inc. (CBUS) Rice Royalty Conversion, Precision-Breeding Platform, and BioFragrance Scale-Up Support Commercial Inflection Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com [email protected] The post Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report appeared first on ExecEdge.

Exec Edge
Evogene and Tel Aviv University launch drug discovery initiative

The partnership will connect Evogene’s AI-based ChemPass AI with the BCDD’s laboratory infrastructure.

Pharmaceutical Technology